These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11147537)

  • 1. Drug costs may top $750 PMPY by 2004.
    Capitation Rates Data; 2000 Oct; 5(10):115-8. PubMed ID: 11147537
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 3. Study shows increases in drug costs may be justified by improvements in outcomes.
    Capitation Rates Data; 2000 Jun; 5(6):65-8. PubMed ID: 11067438
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug spending keeps rising, but rate of increase slowing.
    Capitation Rates Data; 2001 Aug; 6(8):85-9. PubMed ID: 11526857
    [No Abstract]   [Full Text] [Related]  

  • 5. Datawatch: Update on Rx drug spending.
    Bus Health; 2001 Sep; 19(8):48. PubMed ID: 11665673
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic patients spend up to five times more for health care than those without chronic conditions.
    Health Care Strateg Manage; 2001 Dec; 19(12):6-7. PubMed ID: 11799892
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
    Hanley GE; Morgan S
    Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expenditures for prescription drugs: too much or not enough?
    Schumock GT; Walton SM
    Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.
    Wettermark B; Hammar N; Fored CM; Leimanis A; Otterblad Olausson P; Bergman U; Persson I; Sundström A; Westerholm B; Rosén M
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):726-35. PubMed ID: 16897791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient cancer drug costs: changes, drivers, and the future.
    Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
    Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities].
    Andreasen J
    Ugeskr Laeger; 2003 Jul; 165(29):2873-6. PubMed ID: 12908355
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug utilization: national and international comparisons.
    Yosselson-Superstine S
    Isr J Med Sci; 1992 Oct; 28(10):728-30. PubMed ID: 1399504
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription drug trend begins showing modest slowdown.
    Capitation Rates Data; 2002 Jul; 7(7):76-80. PubMed ID: 12164063
    [No Abstract]   [Full Text] [Related]  

  • 14. As drug costs rise, health plans shift the burden.
    Capitation Manag Rep; 1997 Oct; 4(10):153-8. PubMed ID: 10175783
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacy data offer benchmarks for risk contractors.
    Capitation Rates Data; 1998 Feb; 3(2):13-6. PubMed ID: 10345850
    [No Abstract]   [Full Text] [Related]  

  • 16. Use combined drug, diagnostic data to improve cost forecasts.
    Capitation Rates Data; 2005 Feb; 10(2):13-6. PubMed ID: 15859495
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term persistence of high health care costs in a nationally representative sample of children.
    Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
    Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study demonstrates capitation's potential to hold down drug cost.
    Capitation Rates Data; 2001 Aug; 6(8):89-92. PubMed ID: 11526858
    [No Abstract]   [Full Text] [Related]  

  • 20. Managed care outlook. What's behind increases in pharmaceutical spending?
    Manag Care; 1998 Feb; 7(2):70. PubMed ID: 10178891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.